CAR-T cell therapy
-
healthJ&J's Haematology Chief Discusses Myeloma Therapy Advances at EHA 2026
Johnson & Johnson's Ester in 't Groen details how T-cell therapies, like bispecifics and CAR-T, are transforming multiple myeloma treatment and extending patient survival.
-
healthCAR-T Therapy Shows Promise in Refractory Rheumatoid Arthritis at EULAR 2026
Phase 1 trial reveals CAR-T cell therapy induces remission in treatment-refractory rheumatoid arthritis and systemic sclerosis.
-
healthHelios Hospital Doctor Anna Ossami Saidy Honored with Jian-Jian Luan Award
Dr. Anna Ossami Saidy of Helios Hospital Berlin-Buch receives the prestigious Jian-Jian Luan Award for her impactful research in CAR-T cell therapy for lymphoma.
-
healthGroundbreaking CAR-T Cell Therapy Achieves Remission for Autoimmune Patient
Experimental CAR-T cell therapy successfully resets a patient's immune system, leading to complete remission from three severe autoimmune diseases.
-
healthMultiple Myeloma: Early Signs and Treatment Advances
A rare blood cancer affecting plasma cells, multiple myeloma requires early detection. Learn key symptoms, diagnostic criteria, and cutting-edge treatments like CAR-T therapy.